US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 2.730
  • +0.150+5.81%
Close May 17 16:00 ET
  • 2.600
  • -0.130-4.76%
Post 19:18 ET
334.05MMarket Cap-2437P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.59%-32.66M
-242.12%-168.88M
37.61%-31.96M
-184.40%-46.08M
-38.10%-61.83M
-264.61%-29.01M
64.74%-49.36M
-20.82%-51.23M
251.25%54.6M
-29.91%-44.78M
Net income from continuing operations
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
-27.63%-52.22M
Depreciation and amortization
32.60%423K
63.65%1.52M
58.51%447K
100.47%427K
42.73%324K
55.61%319K
8.42%927K
33.65%282K
0.47%213K
10.19%227K
Other non cash items
-0.73%815K
-2.06%3.47M
-1.18%2.93M
12.44%217K
-368.45%-502K
323.20%821K
389.63%3.54M
391.06%2.97M
359.52%193K
379.49%187K
Change In working capital
-186.25%-18.13M
-114.40%-18.76M
-41.66%-19.55M
-107.37%-8.02M
-784.15%-12.21M
-37.10%21.02M
1,192.24%130.32M
-1,619.93%-13.8M
2,498.88%108.92M
10.32%1.79M
-Change in receivables
--0
200.00%30M
--0
--0
--0
--30M
---30M
---30M
--0
--0
-Change in prepaid assets
-6.45%580K
-8.52%3.53M
169.09%3.78M
-14.31%1.75M
-396.48%-2.61M
234.20%620K
241.29%3.86M
2.48%1.4M
221.00%2.04M
137.00%881K
-Change in payables and accrued expense
-82.32%-10.21M
-285.79%-27.02M
-927.21%-12.74M
-164.99%-8.11M
-110.88%-566K
-19.56%-5.6M
11.40%14.54M
372.57%1.54M
196.51%12.48M
9.72%5.2M
-Change in other current assets
----
--0
3.57%-2.05M
11.51%707K
----
----
--0
-1,281.67%-2.13M
-71.88%634K
261.93%604K
-Change in other current liabilities
9.61%-630K
-75.49%-3.14M
-1,467.14%-957K
-15.56%-765K
-16.77%-724K
-20.38%-697K
-37.56%-1.79M
206.06%70K
-14.93%-662K
-71.75%-620K
-Change in other working capital
-138.46%-7.87M
-115.41%-22.14M
-149.52%-7.58M
-101.70%-1.6M
-125.35%-9.65M
-108.63%-3.3M
334,306.98%143.71M
139,300.00%15.31M
858,527.27%94.43M
-42,740.00%-4.28M
Cash from discontinued investing activities
Operating cash flow
-12.59%-32.66M
-242.12%-168.88M
37.61%-31.96M
-184.40%-46.08M
-38.10%-61.83M
-264.61%-29.01M
64.74%-49.36M
-20.82%-51.23M
251.25%54.6M
-29.91%-44.78M
Investing cash flow
Cash flow from continuing investing activities
-5,296.78%-72.55M
178.50%119.88M
144.35%20.15M
729.30%103.78M
93.99%-5.44M
524.32%1.4M
-23,467.28%-152.72M
-29,207.10%-45.43M
-35,750.00%-16.49M
-27,068.17%-90.47M
Net PPE purchase and sale
85.51%-132K
1.32%-2.17M
50.83%-386K
-10.80%-472K
39.27%-399K
-176.90%-911K
-239.04%-2.2M
-406.45%-785K
-826.09%-426K
-97.30%-657K
Net investment purchase and sale
-3,238.93%-72.42M
181.09%122.05M
146.00%20.53M
748.93%104.25M
94.39%-5.04M
--2.31M
---150.52M
---44.64M
---16.07M
---89.81M
Cash from discontinued investing activities
Investing cash flow
-5,296.78%-72.55M
178.50%119.88M
144.35%20.15M
729.30%103.78M
93.99%-5.44M
524.32%1.4M
-23,467.28%-152.72M
-29,207.10%-45.43M
-35,750.00%-16.49M
-27,068.17%-90.47M
Financing cash flow
Cash flow from continuing financing activities
-72.95%5.83M
-38.13%94.68M
-99.78%92K
-101.37%-146K
80.57%73.18M
-64.32%21.55M
140.42%153.02M
43.98%41.46M
2,197.62%10.64M
19.49%40.53M
Net issuance payments of debt
0.00%-65K
-51.47%-412K
-232.31%-216K
0.00%-65K
0.00%-66K
14.47%-65K
-101.48%-272K
-100.35%-65K
0.00%-65K
-60.98%-66K
Net common stock issuance
-73.10%5.85M
-38.01%93.54M
--0
-100.76%-81K
79.78%71.89M
-64.01%21.73M
250.21%150.89M
307.54%39.94M
20,870.59%10.59M
19.94%39.99M
Proceeds from stock option exercised by employees
41.18%48K
-35.39%1.55M
-90.03%158K
--0
123.76%1.36M
-64.58%34K
-3.27%2.4M
207.57%1.58M
-81.00%110K
-2.10%606K
Net other financing activities
----
----
----
--0
--0
---150K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-72.95%5.83M
-38.13%94.68M
-99.78%92K
-101.37%-146K
80.57%73.18M
-64.32%21.55M
140.42%153.02M
43.98%41.46M
2,197.62%10.64M
19.49%40.53M
Net cash flow
Beginning cash position
35.31%175.04M
-27.50%129.36M
1.19%186.76M
-4.86%129.21M
-46.51%123.3M
-27.50%129.36M
-30.14%178.43M
-3.97%184.56M
-40.40%135.82M
0.78%230.54M
Current changes in cash
-1,539.85%-99.38M
193.10%45.68M
78.76%-11.72M
18.07%57.55M
106.24%5.91M
-111.63%-6.06M
36.27%-49.06M
-301.14%-55.2M
236.61%48.74M
-10,602.71%-94.72M
End cash Position
-38.64%75.66M
35.31%175.04M
35.31%175.04M
1.19%186.76M
-4.86%129.21M
-46.51%123.3M
-27.50%129.36M
-27.50%129.36M
-3.97%184.56M
-40.40%135.82M
Free cash flow
-9.60%-32.79M
-231.75%-171.05M
37.81%-32.35M
-185.94%-46.55M
-36.98%-62.23M
-261.13%-29.92M
63.34%-51.56M
-22.23%-52.01M
249.88%54.17M
-30.55%-45.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.59%-32.66M-242.12%-168.88M37.61%-31.96M-184.40%-46.08M-38.10%-61.83M-264.61%-29.01M64.74%-49.36M-20.82%-51.23M251.25%54.6M-29.91%-44.78M
Net income from continuing operations 65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M-27.63%-52.22M
Depreciation and amortization 32.60%423K63.65%1.52M58.51%447K100.47%427K42.73%324K55.61%319K8.42%927K33.65%282K0.47%213K10.19%227K
Other non cash items -0.73%815K-2.06%3.47M-1.18%2.93M12.44%217K-368.45%-502K323.20%821K389.63%3.54M391.06%2.97M359.52%193K379.49%187K
Change In working capital -186.25%-18.13M-114.40%-18.76M-41.66%-19.55M-107.37%-8.02M-784.15%-12.21M-37.10%21.02M1,192.24%130.32M-1,619.93%-13.8M2,498.88%108.92M10.32%1.79M
-Change in receivables --0200.00%30M--0--0--0--30M---30M---30M--0--0
-Change in prepaid assets -6.45%580K-8.52%3.53M169.09%3.78M-14.31%1.75M-396.48%-2.61M234.20%620K241.29%3.86M2.48%1.4M221.00%2.04M137.00%881K
-Change in payables and accrued expense -82.32%-10.21M-285.79%-27.02M-927.21%-12.74M-164.99%-8.11M-110.88%-566K-19.56%-5.6M11.40%14.54M372.57%1.54M196.51%12.48M9.72%5.2M
-Change in other current assets ------03.57%-2.05M11.51%707K----------0-1,281.67%-2.13M-71.88%634K261.93%604K
-Change in other current liabilities 9.61%-630K-75.49%-3.14M-1,467.14%-957K-15.56%-765K-16.77%-724K-20.38%-697K-37.56%-1.79M206.06%70K-14.93%-662K-71.75%-620K
-Change in other working capital -138.46%-7.87M-115.41%-22.14M-149.52%-7.58M-101.70%-1.6M-125.35%-9.65M-108.63%-3.3M334,306.98%143.71M139,300.00%15.31M858,527.27%94.43M-42,740.00%-4.28M
Cash from discontinued investing activities
Operating cash flow -12.59%-32.66M-242.12%-168.88M37.61%-31.96M-184.40%-46.08M-38.10%-61.83M-264.61%-29.01M64.74%-49.36M-20.82%-51.23M251.25%54.6M-29.91%-44.78M
Investing cash flow
Cash flow from continuing investing activities -5,296.78%-72.55M178.50%119.88M144.35%20.15M729.30%103.78M93.99%-5.44M524.32%1.4M-23,467.28%-152.72M-29,207.10%-45.43M-35,750.00%-16.49M-27,068.17%-90.47M
Net PPE purchase and sale 85.51%-132K1.32%-2.17M50.83%-386K-10.80%-472K39.27%-399K-176.90%-911K-239.04%-2.2M-406.45%-785K-826.09%-426K-97.30%-657K
Net investment purchase and sale -3,238.93%-72.42M181.09%122.05M146.00%20.53M748.93%104.25M94.39%-5.04M--2.31M---150.52M---44.64M---16.07M---89.81M
Cash from discontinued investing activities
Investing cash flow -5,296.78%-72.55M178.50%119.88M144.35%20.15M729.30%103.78M93.99%-5.44M524.32%1.4M-23,467.28%-152.72M-29,207.10%-45.43M-35,750.00%-16.49M-27,068.17%-90.47M
Financing cash flow
Cash flow from continuing financing activities -72.95%5.83M-38.13%94.68M-99.78%92K-101.37%-146K80.57%73.18M-64.32%21.55M140.42%153.02M43.98%41.46M2,197.62%10.64M19.49%40.53M
Net issuance payments of debt 0.00%-65K-51.47%-412K-232.31%-216K0.00%-65K0.00%-66K14.47%-65K-101.48%-272K-100.35%-65K0.00%-65K-60.98%-66K
Net common stock issuance -73.10%5.85M-38.01%93.54M--0-100.76%-81K79.78%71.89M-64.01%21.73M250.21%150.89M307.54%39.94M20,870.59%10.59M19.94%39.99M
Proceeds from stock option exercised by employees 41.18%48K-35.39%1.55M-90.03%158K--0123.76%1.36M-64.58%34K-3.27%2.4M207.57%1.58M-81.00%110K-2.10%606K
Net other financing activities --------------0--0---150K----------------
Cash from discontinued financing activities
Financing cash flow -72.95%5.83M-38.13%94.68M-99.78%92K-101.37%-146K80.57%73.18M-64.32%21.55M140.42%153.02M43.98%41.46M2,197.62%10.64M19.49%40.53M
Net cash flow
Beginning cash position 35.31%175.04M-27.50%129.36M1.19%186.76M-4.86%129.21M-46.51%123.3M-27.50%129.36M-30.14%178.43M-3.97%184.56M-40.40%135.82M0.78%230.54M
Current changes in cash -1,539.85%-99.38M193.10%45.68M78.76%-11.72M18.07%57.55M106.24%5.91M-111.63%-6.06M36.27%-49.06M-301.14%-55.2M236.61%48.74M-10,602.71%-94.72M
End cash Position -38.64%75.66M35.31%175.04M35.31%175.04M1.19%186.76M-4.86%129.21M-46.51%123.3M-27.50%129.36M-27.50%129.36M-3.97%184.56M-40.40%135.82M
Free cash flow -9.60%-32.79M-231.75%-171.05M37.81%-32.35M-185.94%-46.55M-36.98%-62.23M-261.13%-29.92M63.34%-51.56M-22.23%-52.01M249.88%54.17M-30.55%-45.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg